Debarati Mukherjee
YOU?
Author Swipe
View article: Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Contains Supplementary Figures 1-4, Supplementary Tables 1-2 and legends for Supplementary Videos 1-4
View article: Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 2
View article: Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 3
View article: Estrogens increase cancer cell efferocytosis to establish an immunosuppressive tumor microenvironment
Estrogens increase cancer cell efferocytosis to establish an immunosuppressive tumor microenvironment Open
Phagocytic clearance of apoptotic cancer cells (efferocytosis) by tumor-associated macrophages (TAMs) contributes in a substantial manner to the establishment of an immunosuppressive tumor microenvironment. This puts in context our observa…
View article: Supplementary Video 3 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 3 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 3
View article: Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Contains Supplementary Figures 1-4, Supplementary Tables 1-2 and legends for Supplementary Videos 1-4
View article: Supplementary Video 3 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 3 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 3
View article: Supplementary Video 4 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 4 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 4
View article: Supplementary Video 1 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 1 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 1
View article: Supplementary Video 4 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 4 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 4
View article: Data from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Data from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Triple-negative breast cancers (TNBCs) tend to become invasive and metastatic at early stages in their development. Despite some treatment successes in early stage localized TNBC, the rate of distant recurrence remains high, and long-term …
View article: Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Contains Supplementary Figures 1-4, Supplementary Tables 1-2 and legends for Supplementary Videos 1-4
View article: Supplementary Video 2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 2
View article: Supplementary Video 1 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 1 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 1
View article: Supplementary Video 2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 2
View article: Inhibition of the Calcium Calmodulin Kinase Kinase-2/phosphodiesterase-1 signaling pathway as a therapeutic approach in metastatic breast cancer.
Inhibition of the Calcium Calmodulin Kinase Kinase-2/phosphodiesterase-1 signaling pathway as a therapeutic approach in metastatic breast cancer. Open
Breast cancer has surpassed lung cancer as the leading cause of cancer incidence, with an estimated 2.3 million new cases in 2020, representing approximately 11.7% of all cancer cases worldwide. It remains the most common cause of cancer-a…
View article: Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2)
Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2) Open
CaMKK2 signals through AMPK-dependent and AMPK-independent pathways to trigger cellular outputs including proliferation, differentiation, and migration, resulting in changes to metabolism, bone mass accrual, neuronal function, hematopoiesi…
View article: Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 1
View article: Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Contains Supplementary Figures 1-4, Supplementary Tables 1-2 and legends for Supplementary Videos 1-4
View article: Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 2
View article: Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 3
View article: Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 1
View article: Data from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Data from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Triple-negative breast cancers (TNBC) tend to become invasive and metastatic at early stages in their development. Despite some treatment successes in early-stage localized TNBC, the rate of distant recurrence remains high, and long-term s…
View article: Supplementary Video 4 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 4 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 4
View article: Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 2
View article: Supplementary Video 4 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 4 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 4
View article: Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 3
View article: Data from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Data from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Triple-negative breast cancers (TNBC) tend to become invasive and metastatic at early stages in their development. Despite some treatment successes in early-stage localized TNBC, the rate of distant recurrence remains high, and long-term s…
View article: Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Contains Supplementary Figures 1-4, Supplementary Tables 1-2 and legends for Supplementary Videos 1-4
View article: Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Triple-negative breast cancers (TNBC) tend to become invasive and metastatic at early stages in their development. Despite some treatment successes in early-stage localized TNBC, the rate of distant recurrence remains high, and long-term s…